NCT00088907: Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer |
|
|
| Terminated | 3 | 270 | US | docetaxel, RP 56976, Taxotere, TXT, placebo, PLCB, gefitinib, Iressa, ZD 1839 | National Cancer Institute (NCI) | Recurrent Head and Neck Cancer, Metastatic Head and Neck Cancer | 05/09 | 08/12 | | |
